Nigrostriatal neurons in rat express the glial cell line-derived neurotrophic factor receptor subunit c-RET

Anatomical Record

Volumn 291, Issue 1, 2008, Pages 49-54

  Wang, Yan Qin ^a   Bian, Gan Lan ^a   Wei, Li Chun ^b   Cao, Rong ^a   Peng, Yi Feng ^a   Chen, Liang Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Basal ganglia; Immunohistochemistry; Neuroprotection; Neurotrophic factors; Parkinson's disease; Retrograde HRP tracing

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; HORSERADISH PEROXIDASE; PROTEIN TYROSINE KINASE; MESSENGER RNA; PROTEIN RET; RET PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL COUNT; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME SUBUNIT; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; ANIMAL; BRAIN MAPPING; ENZYME IMMUNOASSAY; METABOLISM; SPRAGUE DAWLEY RAT;

ARMORACIA RUSTICANA; RATTUS;

ANIMALS; BRAIN MAPPING; CORPUS STRIATUM; IMMUNOENZYME TECHNIQUES; MALE; PROTO-ONCOGENE PROTEINS C-RET; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 40949151204     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20618     Document Type: Article

References (45)

1. Airaksinen MS, Saarma M. 2002. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
2. Arenas E, Trupp M, Akerud P, Ibanez CF. 1995. GDNF prevents degeneration and promote the phenotype of brain noradrenergic neurons in vivo. Neuron 15:1465-1473.
3. Bespalov MM, Saarma M. 2007. GDNF family receptor complexes are emerging drug targets. Trends Pharmacol Sci 28:68-74.
4. Bohn MC, Kozlowski DA, Connor B. 2000. Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of antonia vernadakis on neuronal-glial interactions. Int J Dev Neurosci 18:679-684.
5. Buj-bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. 1995. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15:821-828.
6. Chen LW, Yung KL, Chan YS. 2005. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr Drug Targets 6:821-833.
7. Chen LW, Zhang JP, Shum DKY, Chan YS. 2006. Localization of NGF, NT3 and GDNF in nestin-expressing reactive astrocytes in the caudate-putamen of MPTP-treated C57/BL mice. J Comp Neurol 497:898-909.
8. Choi-Lundberg DL, Bohn MC. 1995. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res Dev Brain Res 85:80-88.
9. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. 1997. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838-841.
10. Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC. 2001. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration. Exp Neurol 169:83-95.
11. Duberley RM, Johnson IP, Martin JE, Anand P. 1998. RET-like immunostaining of spinal motoneurons in amyotrophic lateral sclerosis. Brain Res 789:351-354.
12. Eketjall S, Fainzilber M, Murray-Rust J, Ibanez CF. 1999. Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex. EMBO J 18:5901-5910.
13. Fernandez-Espejo E. 2004. Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. Mol Neurobiol 29:15-30.
14. Gates MA, O'Brien TF, Faissner A, Steindler DA. 1993. Neuron-glial interactions during the in vivo and in vitro development of the nigrostriatal circuit. J Chem Neuroanat 6:179-189.
15. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P. 2003. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589-595.
16. Glazner GW, Mu XJ, Springer JE. 1998. Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system. J Comp Neurol 391:42-49.
17. Gu Y, Chen Y, Ye L. 1992. Electron microscopical demonstration of horseradish peroxidase by use of tetramethylbenzidine as chromogen and sodium tungstate as stabilizer (TMB-ST method): a tracing method with high sensitivity and well preserved ultrastructural tissue. J Neurosci Methods 42:1-10.
18. Honda T, Takahashi M, Sugiura Y. 1999. Co-localization of the glial cell-line derived neurotrophic factor and its functional receptor c-RET in a subpopulation of rat dorsal root ganglion neurons. Neurosci Lett 275:45-48.
19. Kearns CM, Gash DM. 1995. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672:104-111.
20. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
21. Lapchak PA. 1996. Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. Rev Neurosci 7:165-176.
22. Lindholm P, Voutilainen MH, Lauren J, Peranen J, Leppanen VM, Andressoo JO, Lindahl M, Janhunen S, Kalkkinen N, Timmusk T, Tuominen RK, Saarma M. 2007. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448:73-77.
23. Milbrandt J, de Sauvage FJ, Fahrner TJ, Baloh RH, Leitner ML, Tansey MG, Lampe PA, Heuckeroth RO, Kotzbauer PT, Simburger KS, Golden JP, Davies JA. 1998. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20:245-253.
24. Mitsuma N, Yamamoto M, Li M, Ito Y, Mitsuma T, Mutoh T, Takahashi M, Sobue G. 1999. Expression of GDNF receptor (RET and GDNFR alpha) mRNAs in the spinal cord of patients with amyotrophic lateral sclerosis. Brain Res 820:77-85.
25. Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144.
26. Oppenheim RW, Houenou LJ, Johnson JE, Lin LF, Li L, Lo AC, Newsome AL, Prevette DM, Wang S. 1995. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373:344-346.
27. Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, Deglon N, Hantraye P, Aebischer P, Kordower JH. 2002. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22:4942-4954.
28. Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF. 2001. Released GFR alpha 1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29:171-184.
29. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates. Compact 3rd ed. San Diego: Academic Press. p 10-43.
30. Perez-Navarro E, Arenas E, Marco S, Alberch J. 1999. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur J Neurosci 11:241-249.
31. Rye DB, Saper CB, Wainer BH. 1984. Stablization of the tetramethylbenzidine (TMB) reaction product: application for retrograde and anterograde tracing, and combination with immunohistochemistry. J Histochem Cytochem 32:1145-1153.
32. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73.
33. Schlee S, Carmillo P, Whitty A. 2006. Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret. Nat Chem Biol 2:636-644.
34. Schuchardt A, D'Agati V, Larsson BL, Costantini F, Pachnis V. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380-383.
35. Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B. 2005. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg 102:216-222.
36. Tokugawa K, Yamamoto K, Nishiguchi M, Sekine T, Sakai M, Ueki T, Chaki S, Okuyama S. 2003. XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1. Neurochem Int 42:81-86.
37. Trupp M, Ryden M, Jornvall H, Timmusk T, Funakoshi H, Arenas E, Ibanez CF. 1995. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130:137-148.
38. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sarola H, Saarma M, Ibanez CF. 1996. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-788.
39. Trupp M, Belluardo N, Funakoshi H, Ibanez CF. 1997. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 17:3554-3567.
40. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J. 1995. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10:191-198.
41. Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK. Tieu K, Przedborski S. 2001. The role of glial cells in Parkinson's disease. Curr Opin Neurol 14:483-489.
42. Walker DG, Beach TG, Xu R, Lile J, Beck KD, McGeer EG, McGeer PL. 1998. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Res 792:207-217.
43. Williams LR, Inouye G, Cummins V, Pelleymounter MA. 1996. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J Pharmacol Exp Ther 277:1140-1151.
44. Yan Q, Matheson C, Lopez OT. 1995. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344.
45. Yu T, Scully S, Yu Y, Fox GM, Jing S, Zhou R. 1998. Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. J Neurosci 18:4684-4696.